Fundraising FoxCC Bio
2 known investors
Find your way into CC Bio
Sign up to see every warm intro you have to CC Bio
- Paths you didn't know you had: your email and LinkedIn already hold routes to the CC Bio team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
CC Bio develops synthetic biology-based therapeutics to treat microbiome-related diseases by engineering and editing the microbiome with precision. The company uses its proprietary Zeus platform to discover and optimize first-in-class treatments for patients seeking alternatives to antibiotics.
Founders & leadership
DM
Dr Matthew CummingsCo-Founder, CC Bio
DD
Dr David CorcoranCo-Founder, CC Bio
Investors · 2
CMS Venturesreported
How we know: funding news · press coverage · Not right? Tell us
Frequently asked questions
- What does CC Bio do?
- CC Bio develops synthetic biology-based therapeutics to treat microbiome-related diseases by engineering and editing the microbiome with precision. The company uses its proprietary Zeus platform to discover and optimize first-in-class treatments for patients seeking alternatives to antibiotics.
- Who founded CC Bio?
- CC Bio was founded by Dr Matthew Cummings, Dr David Corcoran.
- Who are CC Bio's investors?
- CC Bio's investors include Deep Science Ventures, CMS Ventures.